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ABSTRACT 
 
IDENTIFICATION OF A NOVEL TRANSCRIPTIONAL REPRESSOR GENE IN KUMAO, A 
GENETICALLY UNIQUE BACTERIOPHAGE 
 
Lori Marie Neri, M.S.  
 
Western Carolina University (March 2020) 
 
Director: Dr. Maria Gainey  
 
 
Kumao is a genetically unique bacteriophage that infects Mycobacterium smegmatis (M.  
 
smegmatis) and was selected for further study because of its noncanonical genome arrangement.  
 
As an example, integrase genes are typically located at the center of Mycobacteriophage  
 
genomes.  However, Kumao and cluster M bacteriophages contain an integrase gene located on  
 
the right side of the genome. Kumao and cluster M bacteriophages also contain a leftward  
 
transcribed operon containing genes of unknown function directly upstream of their structural  
 
genes. Kumao lysogens were successfully generated, proving that Kumao is indeed a  
 
temperate bacteriophage, but bioinformatics has failed to reveal an obvious repressor gene  
 
candidate.  Repressor genes are typically located at a transcriptional directional change and are  
 
the first gene of a leftward transcribed operon. Repressor genes are also usually located near the  
 
integrase gene and contain an easily predicted helix-turn-helix DNA binding motif.   
 
Current work is focused on identifying the location of Kumao’s repressor gene using two  
 
different functional screens. The first involves overexpressing individual Kumao genes in M.  
 
smegmatis and performing a viral challenge experiment. If the gene is the repressor then  
 
productive viral replication should be inhibited. This approach was recently used to identify the  
 
 
vi 
repressor gene of cluster M bacteriophages, gene 1. Gene 1 is located at the end of the leftward  
 
transcribed operon upstream of the structural genes. Twenty-one Kumao genes were selected for  
 
testing, based on their proximity to the integrase gene, nearness to a transcriptional direction  
 
change, or potential promoter region. Excitingly, the results reveal that genes 5 and 44 have been  
 
found to be promising repressor candidates. The second approach involves CRISPRi of Kumao’s  
 
operons during lysogeny. If the operon containing the repressor is silenced, Kumao should  
 
reenter the lytic replication cycle. CRISPRi vector constructs that will target Kumao’s operons  
 
and a positive control targeting IPhane7’s repressor operon have been successfully generated.  
 
The CRISPRi system constructs were validated using genes 1 and 2 from IPhane7. However,  
 
further testing is needed to optimize the CRISPRi system.  
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CHAPTER ONE: INTRODUCTION  
 
 
Bacteriophages, or phages, are the most abundant and diverse life forms on earth.  
 
Bacteriophages are viruses that infect bacteria and can either undergo a lytic or lysogenic  
 
replication cycle. Both cycles begin when a viral particle attaches to receptors located on the  
 
bacterial cell surface. The virus then injects its DNA inside the host cell, and it is after this event  
 
that the lytic and lysogenic cycles diverge.1,2 During lytic replication, viral DNA will serve as the  
 
template for transcription, and many new viral particles will be produced resulting in cell death.3  
 
In the lysogenic replication cycle, the injected DNA integrates into the host’s genome, (which is  
 
called a prophage, and the bacterial cell containing a prophage is known as a lysogen) and  
 
remains dormant for long periods of time.1 While remaining dormant, the host is unaware of the  
 
invasion and will undergo cell division like normal, with the prophage transmitted to newly  
 
produced cells. This process will continue until the lytic replication cycle is induced.1 Phages  
 
that undergo lysogeny are also referred to as temperate bacteriophages and these phages typically  
 
have an integrase and a repressor protein. The integrase is responsible for integrating viral DNA  
 
into the hosts DNA, and the repressor is responsible for stopping transcription of viral genes that  
 
allows the phage to enter the lytic replication cycle.4 Due to their coevolution with their hosts,  
 
bacteriophages are also great resources for understanding the evolution and genetic diversity of  
 
the bacterial cells they infect.5,6 
 
Mycobacteriophages are viruses that infect Mycobacterium hosts such as  
 
M. smegmatis and M. tuberculosis. Over 1,877 Mycobacteriophages have been sequenced and  
 
archived through the Science Education Alliance-Phage Hunters Advancing Genomics and  
 
Evolutionary Sciences (SEA-PHAGES) program, resulting in the largest collection sequences of  
 
1 
phages that infect a single host currently in exhistence.4,6,7 Most of the Mycobacteriophage  
 
genomes have a canonical structure in which the genome starts with the assembly and structural  
 
genes transcribed in the forward (rightward) direction. If it is a temperate phage both the  
 
integrase and the repressor are found relatively near each other in the center of the genome,  
 
typically near a transcription directional change.4 However, as was first discovered in Cluster M  
 
phages this is not always the case and that noncanonical genome arrangements do exist. Cluster  
 
M phage genomes begin with a leftward transcribed operon containing genes of unknown  
 
function. In addition, unlike other temperate bacteriophages, the integrase protein is located in  
 
the right arm of the genome, and no repressor gene can be called using bioinformatics.4 IPhane7  
 
is a Cluster M bacteriophage discovered at Western Carolina University that has recently been  
 
under study in the Gainey laboratory by Erin Cafferty. Excitingly, Erin was able to recently  
 
identify a novel transcriptional repressor in the IPhane7 genome.8  
 
It was then sought to determine if other Mycobacteriophages also exhibited this  
 
noncanonical arrangement. The genome architecture of every cluster of Mycobacteriophage was  
 
examined using the Actinobacteriophage database9 and Phamerator10 Bacteriophage Kumao, a  
 
singleton, was discovered and annotated at Lehigh University in Pennsylvania.9 Kumao is  
 
considered a “singleton” because it was unable to be classified into a cluster with other  
 
Mycobacteriophages because it does not contain greater than fifty-percent nucleotide similarity  
 
to any other sequenced bacteriophages. However, upon further inspection of Kumao’s genome  
 
architecture it was observed that Kumao did exhibit some similarities to Cluster M  
 
bacteriophages. As an example, Kumao’s genome also begins with a leftward transcribed  
 
operon, and an integrase gene is found on the right arm of Kumao’s genome.   
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A visual representation of Kumao’s genome is shown below in Figure 1.  
 
 
Figure 1. A Phamerator map of Kumao’s genome divided into four tiers. Each box represents a 
gene in Kumao’s genome. The ruler indicates how long the genome is, and each number 
represents 1,000 base pairs. The genes located at the bottom of the ruler is moving left in the 
reverse direction and the genes located above the ruler is moving right in the forward direction. 
The different colors of the genes indicate that those genes are found in other bacteriophages and 
the genes that are white indicate they are unique to that bacteriophage. Stars represent genes that 
were selected for testing in the overexpression assay, while arrow represent areas of the genome 
that CRISPRi targets were generated against. The yellow box indicates the integrase protein.   
 
Kumao was selected for further study because temperate phages make up most of the  
 
bacteriophage population. However, little is known about how they control and regulate their  
 
lytic verses lysogenic replication cycles.4 Control of gene expression is essential for biological  
 
systems to function properly. The more these phages are studied, especially the unique ones, the  
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more we will learn about the evolution of gene expression control mechanisms.5  
 
There is currently a rise of antibiotic resistant bacteria, and new alternatives are needed to  
 
treat these pathogens. One of these alternatives is phage therapy, because phages are naturally  
 
antibacterial and are active against even multi-drug resistant bacteria. Phage therapy is more  
 
specific than existing drugs and is able to limit the death to non-targeted bacteria.1,11 However,  
 
current limitations of phage therapy include that the exact microorganism causing the infection  
 
along with a panel of phages that infect it needs to be known for accurate treatment. Also,  
 
therapy is currently limited to the use of lytic phages, or temperate bacteriophages that have been  
 
genetically altered such that they can no longer enter into the temperate cycle.11,12 If their  
 
repressor systems are not known or fully understood, these viruses cannot be genetically  
 
engineered for bacteriophage therapies. The goal of my thesis work is to prove that Kumao is a  
 
temperate bacteriophage, identify a novel repressor system in bacteriophage Kumao, and develop  
 
a CRIPSRi method as another way to indentify repressors.  
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CHAPTER TWO: METHODS 
 
 
Viral Stock Growth 
 
Bacteriophage Kumao was discovered by a student at Lehigh University in Easton, PA  
 
through the SEA-PHAGES program in 2015.8 Bacteriophage IPhane7 was discovered at Western  
 
Carolina University in 2016 by Dylan Rood from Dr. Charles Marth’s compost. Bacteriophage  
 
Larva was discovered at the college of William and Mary in Williamsburg, VA in 2010.13  
 
Bacteriophage Nanosmite was discovered at Del Mar College in Corpus Christi, TX in 2015. 
 
 All viruses except IPhane7 were obtained from the Hatfull laboratory SEA-PHAGES  
 
archive.  IPhane7 was obtained from the Western Carolina University bacteriophage archive.   
 
Viruses were plaque picked once for purity. Viral stocks were created by flooding webbed plates  
 
with phage buffer followed by 0.22 µM filtration as described by the SEA-PHAGES laboratory  
 
protocols.14 All virus stocks were stored at 4 °C.  
 
Lysogen Creation and Testing 
 
A Kumao lysogen was created by following the Lysogeny experiment protocol.15 Briefly,  
 
bacteriophage Kumao was serially diluted and spotted onto a top agar lawn containing M.  
 
smegmatis cells. This plate was inverted and incubated at 37 °C until mesas were observed.  
 
Mesas are an overgrowth of bacterial cells. Bacteria in the mesas were then streaked onto fresh  
 
plates, and 6-8 colonies were selected for a second round of streaking, followed by patch testing.  
 
During a patch test, potential lysogen cells are streaked onto a top agar layer containing M.  
 
smegmatis and should show evidence of virus “leakage” from these cells. Colonies that had  
 
positive patch tests were grown in liquid culture and a Kumao viral challenge experiment was  
 
performed to confirm that they were indeed Kumao lysogen cells.15    
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pSMEG Overexpression Vector 
 
The pSMEG overexpression vector was obtained from Danielle Heller (Howard Hughes  
 
Medical Institute).  Individual viral genes were amplified by PCR from boiled virus stocks using  
 
Q5 Hot Start High Fidelity 2x Master Mix (New England Biolabs) protocols. Forward and  
 
reverse primers were designed to amplify the indicated viral genes from start codon to stop  
 
codon and are shown in Table 1.  If the gene start codon was not ATG, the forward primer was  
 
altered such that the start codon in the final construct would be changed to ATG. The pSMEG  
 
vector sequence 5’-ATGCGGAGGAATCACTTCCAT-3’ was then added to the 5’end of the  
 
forward primer and 5’-TGCAGGATCCGACTCGAGTGTCGAC-3’ to the 5’end of the reverse  
 
primer to enable HiFi assembly of amplified genes into the linearized pSMEG vector.16 The  
 
pSMEG vector was linearized and amplified using primers shown in Table 1. All primers  
 
were ordered from Integrated DNA Technologies. PCR products were size-verified by gel  
 
electrophoresis and purified following protocols from New England Biolabs Monarch PCR and  
 
DNA clean up kit. Individual genes were then ligated into the linearized pSMEG vector  
 
following the HiFi assembly master mix protocols from New England Biolabs.16   
 
Plasmids were transformed following manufacture protocols into NEB 5-alpha  
 
competent E. coli cells and plated onto Luria Broth (LB) agar plates plus 50 µg/mL kanamycin. 
 
Successful transformants were then identified using colony PCR.16 Successful colonies were  
 
amplified by using 5 mL overnight LB 50 µg/mL kanamycin cultures and plasmids purified  
 
following protocols from New England Biolabs Monarch Plasmid Miniprep. These plasmids  
 
were quantified using a Thermo Scientific Nanodrop 2000 Spectrophotometer and sequences  
 
were verified using Sanger sequencing.16   
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Table 1. pSMEG and Kumao gene primers used to perform the overexpression assays.  
All primers are listed in the 5’ to 3’ direction, and the pSMEG vector  
sequence for each gene is highlighted in yellow.  
 
 
 
CRISPR interference: pLJR965 Cloning 
 
  The pLJR965 plasmid was a kind gift from the Fortune laboratory.  Forward and reverse  
 
primers were designed to target the operon indicated in Table 2 according to Fortune lab protocol  
 
version 4.17 Briefly, a PAM sequence was identified for the non-template strand for each sgRNA  
 
sequence to maximize gene knockdown.17 The sgRNA targeted sequence is ~20 nucleotides in  
 
length, with the last nucleotide being either an A or G. The pLJR965 vector sequence 5’-GGGA- 
 
3’ was then added to the 5’ end of the forward primer and 5’-AAAC-3’ was added to the 5’end  
 
of the reverse primer to enable insertion via gateway assembly into the pLJR965 vector. Forward  
 
and reverse primers used are shown in Table 2. Individual colonies were picked and amplified  
 
using liquid culture and then plasmids were purified using New England Biolabs Monarch  
 
Plasmid Miniprep kit. Plasmid DNA was quantified using a Thermo Scientific Nanodrop 2000  
 
Spectrophotometer and sequences were verified using Sanger sequencing.17  
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Table 2.  CRISPRi, Kumao, and Iphane7 gene primers used to perform CRISPRi. All primers are 
listed in the 5’ to 3’ direction and highlighted in yellow is the CRISPRi vector sequence added 
for each gene.  
 
 
pSMEG Overexpression Assay 
 
Approximately 100 ng of pSMEG DNA alone, or pSMEG containing the indicated gene  
 
was electroporated into electrocompetent M. smegmatis cells.16 A volume of 2.5 µL of plasmid  
 
DNA was added to 50 µL of cells and incubated on ice for 10 min. The cells were then  
 
transferred into a 1mm electroporation cuvette, and a single electric pulse at 1.8 kV, with no time  
 
constant, was delivered using a BioRad GenePulser Xcell system.16 Cells were then transferred  
 
from the cuvette to a microcentrifuge tube using 1 mL of 7H9 complete, which consisted of 7H9  
 
neat, AD supplement, and 100 mM concertation of CaCl2. The cells were incubated with shaking  
 
at 37 °C at 250 rpm for 2 hr and then 150-250 µL of the cells were plated on to 7H9 agar  
 
plates with 5 µg/mL of kanamycin. The plates were incubated for 4-5 days at 37 °C to allow  
 
colony growth. After successful colony growth, a 5 mL culture with and without the inducer, 5  
 
ng/mL anhydrous tetracycline (aTC), was grown for two days.16 All cultures included 7H9  
 
complete media, 5 µg/mL of kanamycin, 12.5 µL 20% tween80, and a single bacterial colony. A  
 
bacterial lawn was then made with 500 µL of bacterial culture, mixed with 4.5 mL of 7H9 top  
 
agar plus 5 µg/mL kanamycin, and plus or minus 5 ng/mL anhydrous tetracycline. The top agar  
 
mixture was plated onto 7H9 plates plus kanamycin (5 µg/mL) plus or minus aTC (5 ng/mL).  
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About 2.5 µL of ten-fold serial dilutions of the indicated viruses were then plated onto the top  
 
agar layers. Plates were then incubated at 37 °C for two days.16    
 
Kumao Gene Toxicity Testing 
 
A single bacterial colony containing pSMEG, or pSMEG plus the indicated Kumao gene,  
 
was inoculated into 500 µL of 7H9 neat media and then resuspended. Ten-fold serial dilutions of  
 
these cells were performed using 7H9 neat media (10-1 to 10-5 log), and 5 µL was spotted onto  
 
7H9 agar plates plus kanamycin (5 µg/mL) with or without aTC (5 ng/mL) plates. Kanamycin is  
 
used as an antibiotic. The plates were then incubated at 37 ºC for 5 days.16  
 
CRISPRi 
 
  100 ng of pLJR965 DNA was electroporated into electrocompetent IPhane7 lysogen  
 
cells as described above for the pSMEG plasmids.16 After successful colony growth, a 5 mL  
 
culture with 7H9 complete media plus 2.5 µL 20% tween80 and kanamycin (5µg/mL) was 
 
incubated for 2 days at 37 °C.17 A 50-fold dilution of this culture was added to a 125 mL baffled  
 
flask containing 25 mL of 7H9 complete media, 2.5 kanamycin (5 µg/mL), and plus or minus  
 
aTC (5 ng/mL). Before incubating, a time point of t0 was recorded by removing 1 mL of culture  
 
and collecting the supernatant after 1 minute of max speed centrifugation. Subsequent time  
 
points were taken once a day for 5 days and stored at 4 °C.  Spot titers were performed in  
 
triplicate for each time point. The spot test was performed on LB agar plates with a bacteria lawn  
 
consisting of M. smegmatis and top agar. Approximately, 2 µL of sample was spotted and  
 
incubated at 37 °C for 1-2 days.16 
 
Creating Electrocompetent IPhane7 Lysogen Cells 
 
 Fresh colonies of IPhane7 lysogen cells were grown from an IPhane7 lysogen glycerol  
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stock created by former student Erin Cafferty. Approximately, 3 mL liquid cultures (7H9  
 
complete) were grown from a single bacterial colony for 2 days at 37 °C. After 2 days the culture  
 
was inoculated into a 250 mL baffled flask containing 50 mL of 7H9 complete media to an  
 
optical density of 600 (OD600) and incubated with shaking at 37 °C overnight. Once the OD600  
 
reached between 0.8-1, cells were pelleted using the Beckman Coulter Allegra X-I5R Centrifuge  
 
at 4,500 rpm for 10 min at 4 °C. The cells were washed and resuspended with 10% cold  
 
glycerol. This process was repeated four times to ensure all salts were removed. Cells were  
 
resuspended in 10% cold glycerol and aliquoted 1 mL into Eppendorf tubes, then flash frozen  
 
using dry ice and stored at -80 °C until electroporation.  
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CHAPTER THREE: RESULTS 
 
 
Lysogen Creation and Testing 
 
 To determine if Kumao is a temperate bacteriophage, Kumao lysogens were attempted to  
 
be made. When ten-fold serial dilutions of Kumao were spotted onto M. smegmatis lawns mesas  
 
(islands of bacterial growth in the presence of high virus concentrations) readily formed after  
 
several days of incubation. An example of a mesa formed by Kumao is shown below in Figure 2.  
 
Cells from this mesa were then subject to several rounds of purification and tested for the  
 
presence of virus using a patch test shown below in Figure 3. As shown in Figure 3, candidate  
 
cells 1, 5, 8, 10, and 11 show evidence of small virus plaques around the area where the cells  
 
were streaked, indicating that these could be lysogen cells. Positive lysogen candidate cells from  
 
the patch test were then used to create a bacterial lawn onto which serial dilutions of Kumao,  
 
IPhane7, and Larva viruses were spotted. Larva was used as a control because it has been  
 
previously studied in the Gainey Laboratory and has a canonical temperate bacteriophage  
 
genome architecture. If the cells were indeed a Kumao lysogen, they should be resistant to cell  
 
death from bacteriophage Kumao (homoimmunity) but not bacteriophages IPhane7 and Larva.  
 
An example of the results from colony 10 are shown in Figure 4. As expected, bacteriophage  
 
Kumao was able to readily infect M. smegmatis control cells, but not a lawn of the potential  
 
Kumao lysogen cells, indicating that these cells are indeed likely to be Kumao lysogens and that  
 
Kumao is a temperate bacteriophage.  
 
 
 
 
 
 
 
11 
 
Figure 2a. Ten-fold serial dilution of Kumao. Dilutions were spotted in duplicate onto a top agar 
layer containing M. smegmatis. A close up of the bottom 100 mesa is shown in 2b. The puncture 
in the agar shows where potential lysogen cells were collected from the mesa for further 
purification and testing. 
 
 
Figure 3. Patch test of twelve different bacterial colonies streaked from the mesa. Bacteria from 
colonies 1-12 were individually streaked onto a top agar layer containing M. smegmatis cells as 
indicated by the number above the streak.  The dark circles around the streak as seen in 1, 5, 8, 
10, and 11 indicate cell lysis, where virus is leaking from lysogen cells. 
 
 
Figure 4. Kumao lysogen challenge experiment. Bacteriophages Kumao, IPhane7, and Larva 
were serially diluted and spotted onto top agar layers containing control M. smegmatis cells or 
lysogen candidate 10 cells.   
 
pSMEG Overexpression Assay 
 
 After successfully proving that Kumao is indeed a temperate bacteriophage, twenty-one  
 
repressor gene candidates were selected for testing. Candidate genes were selected based on  
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previous knowledge of repressor location, such as proximity to the integrase gene and switches  
 
in transcriptional direction. The non-canonical genome location of IPhane7’s recently discovered  
 
repressor gene was also taken into account.8 Candidate genes selected for testing are shown in  
 
Table 1. Figure 5 shows a representative experiment from this experimental series. Candidate  
 
genes were individually cloned into the pSMEG overexpression vector and electroporated into  
 
M. smegmatis cells. Liquid cultures of cells containing pSMEG (negative control), pSMEG plus  
 
a candidate gene, or pSMEG plus the repressor gene from bacteriophage Larva (positive control)  
 
were then grown in the presence or absence of inducer. The indicated viruses were then serially  
 
diluted and spotted onto plates with top agar layers of these cells. Gene 42 from bacteriophage  
 
Larva performed as expected and reduced the growth of bacteriophage Larva by ~3 logs even in  
 
the absence of inducer, and 6 logs in the presence of inducer, but had no effect on the growth of  
 
bacteriophages Kumao or Iphane7. Excitingly, both gene 5 and 44 from Kumao were able to  
 
inhibit the growth of bacteriophage Kumao. A summary of the results from the remaining genes  
 
tested can be found in Table 3.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13 
 
Figure 5a. Bacteriophages Kumao, IPhane7, and Larva were serially diluted and spotted onto top 
agar layers of M. smegmatis cells containing pSMEG plasmids plus the indicated Kumao genes, 
in the presence of absence of an inducer. Kumao was spotted in duplicate. Bacteriophage Larva’s 
repressor, gene 42 was used as a positive control (a). The (-) indicates without inducer, the (+) 
indicates plus inducer. The images located on the left side without inducer, all viruses should 
produce plaques, which is indicated by the dark circles. The images on the right-hand side are 
with inducer and if the repressor is present then no plaques will be formed because 
bacteriophages are homoimmune to themselves, meaning they cannot infect themselves. For 5a 
Larva was a control and you can see that gene 42 is its repressor because Larva produced no 
plaques with inducer. For Kumao’s genes 1 and 2, plaques appeared for both genes indicating 
that those genes are not the repressor. Gene 5 and 44 Kumao produced very faint plaques, and 
the red boxes indicate the area of interest for both genes. Since both produced very faint plaques, 
they are possible candidates for being Kumao’s repressor.  
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Table 3.  Kumao repressor gene candidates tested.  
 
 
Gene Toxicity 
 
 In addition to repressor testing, a toxicity test was performed using the bacterial colonies  
 
containing pSMEG plus individual Kumao genes. The bacterial colonies for each are  
 
resuspended in media and then serially diluted onto plates with and without the inducer. Figure 6  
 
shows example results for genes 1, 10, 99, and 100. An absence of bacterial growth in the  
 
presence of the inducer such as is seen for gene 10 indicates that expression of the gene may be  
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toxic. Gene 10 also has very minimal bacterial growth without inducer, further indicating its  
 
toxicity. A summary of the results from all genes tested can be found in Table 4.  
 
 
Figure 6. M. smegmatis bacterial colonies. Kumao genes 1, 10, 99, and 100 were serially diluted, 
and then spotted onto plates in the presence (+) and absence (-) of the inducer. If a gene is toxic 
no bacterial colonies will grow in the presence of inducer, gene 10 is a great example of that.  
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Table 4. Kumao gene candidates tested for toxicity. The dashes indicate that those genes have 
not been tested yet.  
 
 
CRISPRi 
 
 An alternative approach to determine the location of a repressor gene is to 
 
transcriptionally silence candidate operons using CRISPRi in lysogen cells. Transcription of the  
 
operon that contains the repressor gene should be active during lysogeny. If the transcription of  
 
the repressor gene is silenced, the concentration of repressor protein inside the cells should drop  
 
over time to levels that are too low to maintain lysogeny, and the lytic replication cycle should  
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resume. Kumao gene candidates for transcriptional silencing were selected based on their  
 
relation to the start of an operon and on previous knowledge of repressor location.17 Table 2  
 
shows the genes candidates selected for testing. However, since this system has never been  
 
tested, IPhane7 lysogens were used as a positive control, since its repressor location is known.  
 
Sequences designed to target IPhane7’s gene 1 and 2 were cloned into the pLJR965 vector and  
 
electroporated into M. smegmatis cells. Liquid cultures of the cells with tween were grown first  
 
and then split from this culture into media plus or minus an inducer that will turn on expression  
 
of the CRISPRi system. Time points were taken of each sample for five days. Figures 7 and 8  
 
show the results of this experiment. Figure 7 shows the raw spot titer data which was spotted in  
 
triplicate for each time point tested. Figure 8 shows the graphical representation from Figure 7,  
 
in which the average of each data was graphed. This experiment was performed in three time 
 
and data spotted in triplicate. In Figure 7, on the first day, t0, both genes show very minimal spot  
 
titer with and without inducer, this is expected as the cultures did not have a chance to incubate  
 
yet. After twenty-four hours, there is an increase for both genes in the amount of virus that is  
 
present with and without inducer. After twenty-four hours for both genes there is a significant  
 
drop in the amount of virus present. Figure 8 shows the average calculated spot titer for Figure 7,  
 
and gene 1 there is a slight increase in the amount of virus with inducer, compared to without  
 
inducer. For gene 2 there is not much of a difference with and without inducer, as compared to  
 
gene 1.   
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Figure 7. Viral titer of IPhane7 genes 1 and 2. Each timepoint with and without inducer was 
spotted in triplicate. t0-t120 represents the twenty-four hour time points taken over five days. The 
dark circles represent the viral plaques.  
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Figure 8a. IPhane7 Viral Titer for Gene 1 with and without inducer. (b) IPhane7 Viral Titer for 
Gene 2 with and without inducer. The plots represent the average of the viral titer plaques that 
was performed in triplicate as seen in Figure 7.  
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CHAPTER FOUR: DISCUSSION 
 
 
Lysogeny Creation and Testing 
 
 Kumao was successfully proven that it is a temperate bacteriophage because Kumao  
 
lysogens were able to be isolated as seen in Figures 2-4. This result was expected due to the  
 
features in Kumao’s genome because Kumao has an integrase protein even though  
 
bioinformatics failed to identify a repressor protein.10 Temperate phages need an integrase  
 
protein so that the virus’s DNA is able to insert its DNA into the hosts DNA. The repressor  
 
protein is then usually found relatively near the integrase because it stops transcription from  
 
entering the lytic replication cycle. Even though Kumao only had the integrase protein called,  
 
this was a good indicator that it was likely to be a temperate bacteriophage.  
 
pSMEG Overexpression Assay 
 
 As shown in Figure 5a, overexpression of Larva’s repressor gene completely  
 
inhibits Larva viral replication, but not the replication of IPhane7 or Kumao. In fact, even  
 
without the presence of inducer a small amount of leaky expression from the pSMEG vector was  
 
sufficient to cause an ~3 log inhibition of Larva virus replication.  
 
 Kumao’s four candidate genes tested, as seen in Figure 5, are genes 1, 2, 5, and 44. Genes  
 
1 and 2 were selected because previous results from our laboratory have8 revealed that IPhane7  
 
gene 1 is the repressor and gene 2 seems to synergize with gene 1 to completely inhibit virus  
 
replication (data not shown). Testing of Kumao’s gene 1 and 2 indicated they are not the  
 
repressor, as overexpression of these genes did not cause a significant decrease in virus  
 
replication of Kumao.  In addition, gene 1 and gene 2 showed no significant effect on IPhane7  
 
replication. This is because gene 1 for both Kumao and IPhane7 are from different families.4,10 
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Even though gene 2 for both bacteriophages belong to the same gene family, when their 
 
sequences are aligned, they do not align well and are very different from one another. This is  
 
why Kumao’s gene 2 had no significant effect on IPhane7 replication. Kumao’s gene 5 and  
 
gene 44, seen in Figures 3d and 3e, showed the most promising results because both genes had  
 
almost complete inhibition of Kumao replication. Kumao gene 5 is very promising as the  
 
repressor gene candidate compared to gene 44 because the few spots that did appear are very  
 
faint, and gene 5 overall caused an ~5 log inhibition. Gene 5 is also considered an orpham  
 
because it is not found in any other bacteriophage and is unique to Kumao. This makes it a more  
 
promising candidate as the repressor because it is unique to Kumao. This is not normal  
 
for repressors that is currently known as repressors are typically able to be identified by  
 
bioinformatics and are found in other phages and are not considered orphams.12 Gene 5 is also  
 
found in Kumao’s first operon, which is where IPhane7’s repressor was also found. The cell  
 
lawns for containing gene 44, as compared to gene 5, were lighter, indicating some toxicity from  
 
overexpression of gene 5 that could have reduced viral replication because the cells were sick.  
 
Also, gene 44 is likely not the repressor because it is in the same operon as the integrase and  
 
typically the integrase and the repressor are found going in different transcriptional directions.12  
 
Gene 5 and gene 44 amino acid sequences were determined through Phyre18 and I-TASSER19,  
 
which are protein structure prediction software’s. Phyre for both genes did not show a helix-turn- 
 
helix motif structure, which is characteristic of most. However, I-TASSER did show that gene 5  
 
did have a helix-turn-helix and gene 44 did not. This further suggests gene 5 is the repressor  
 
compared to gene 44. More testing will have to be done on both genes to verify gene 5 is indeed  
 
Kumao’s repressor.  
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Gene Toxicity 
 
 This experimental series was conducted as a part of a collaboration with Viknesh  
 
Sivanathan and Danielle Heller and their new SEA-GENES (Gene-Function  
 
Elucidation by a Network of Emerging Scientists) initiative. The goal of this initiative is to  
 
determine the function of novel bacteriophage proteins. They are initially focused on discovering  
 
novel toxic genes and then determining if their cellular pathways are good therapeutic targets.  
 
Gene 10 was the only gene tested so far that was proven to be toxic, which was expected because  
 
it did not grow any bacterial cultures with inducer. Gene 99 was predicted to be toxic because it  
 
did not grow in liquid with inducer. Although it did produce some colonies, they were small and  
 
not as fluffy as compared to the colonies gene 1 and 100 produced. This is usually an indicator  
 
that the cells are not well but the gene is not completely toxic. Both genes 10 and 99 are only  
 
found in Kumao and haven an unknown function.  
 
CRISPRi 
 
 Due to this method never being done before within a lysogen, it was initially  
 
hypothesized that if the repressor is present, the culture with inducer would turn the repressor off  
 
and the virus would come out and kill the host, resulting in a clear culture. This was not the case,  
 
and the cultures with inducer remained cloudy. This result led to taking time point samples of the  
 
cultures of IPhane7’s gene 1 and 2 over the course of five days to see if there was an increase in  
 
virus activity. As seen in Figure 7, time points were taken over the course of five days for both  
 
genes 1 and 2 with and without inducer. The most amount of virus activity was on the second  
 
day for both genes 1 and 2, and there was not much of a difference between the two genes and  
 
not a significant difference with and without inducer. After the second day there is little to no  
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virus activity as indicated by the lack of plaques. Gene 1 there is no virus activity at t48 and then  
 
there is very minimal activity at t72. There is a possibility that there was an experimental error,  
 
since gene 2 showed virus activity at t48. Figure 8 shows the graphical representation of the  
 
viral titer on both genes to see if there was a difference with and without inducer since visually  
 
there was not much of a difference. There is a slight increase within viral titer with the inducer  
 
for gene 1. This increase is the expected outcome because more virus should come out. Although  
 
there is not a drastic difference with and without the presence of inducer. There is a possibility  
 
with this method that there is not going to be a drastic difference with cultures in the presence  
 
and absence of inducer it may only be a subtle difference. For future experiments, it will be  
 
important to compare how the cultures look testing an operon in IPhane7 that does not have the  
 
repressor to see if there is a difference. Also, future experiments could target Larva’s repressor to  
 
see if it produces the same results that IPhane7 produced. Although optimization is still required,  
 
the foundation has been laid to use CRISPRi to find a repressor within a lysogen.  
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CHAPTER FIVE: CONCLUSIONS AND FUTURE WORK 
 
 
By understanding and further analyzing temperate bacteriophages and their repressor  
 
proteins it can help contribute to further understanding genetic evolution, and contribute to  
 
phage therapy being more assessable to treat antibiotic resistant bacteria. Phages are naturally  
 
antibacterial and are active against even multi-drug resistant bacteria. Phage therapy is more  
 
specific than existing drugs and is able to limit the destruction done to non-targeted bacteria.1,11  
 
If gene 5 is Kumao’s repressor, it is novel because it does not fit the standard structure of where  
 
repressors are located, and this information will help provide further understanding of temperate  
 
phages.1,5 Control of gene expression is essential for biological systems to function properly. The  
 
more these phages are studied, especially the unique ones, the more that can be learned about the  
 
evolution of gene expression control mechanisms.1,5 
 
Kumao’s gene 5 will undergo further testing to verify that it is the repressor. One of the  
 
methods is using a single expression assay, with pMH94 as the vector instead of the  
 
overexpression assay that was used. The difference between the two methods is the single  
 
expression assay a single copy of the gene is expressed, whereas in with the overexpression  
 
assay multiple copies of the gene are expressed. pMH94 also uses a natural promoter compared  
 
to pSMEG, which uses an inducer to turn the repressor on. However, some genes when  
 
overexpressed become toxic which is what is believed gene 44 is doing. Since the single  
 
expression assay only gives a single copy of the gene, it can then be determined that gene 44 is  
 
not the repressor. Once the repressor is validated, biochemical characterization will be performed  
 
on the repressor protein. This includes small-and large-scale protein expression and purification,  
 
determining what sequence the repressor binds, and then determining binding stoichiometry  
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using small-angle x-ray scattering (SAXS), and crystallization.  
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